Royalty Pharma to Highlight Accomplishments and Provide Business Update at 43rd Annual J.P ...
Portfolio Receipts expected to be approximately $2,800 million, at the upper end of guidance rangeExciting development-stage pipeline with ...
Insmed Provides Business Update at 43rd Annual J.P. Morgan Healthcare Conference
Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and ...